Answers are grounded in this paper and cite their sources.
Riboflavin (vitamin B2) is essential to all organisms as it is the universal precursor to cofactors FAD and FMN. While animals lack riboflavin biosynthetic enzymes and obtain riboflavin from dietary sources of riboflavin, many pathogenic bacteria rely on endogenously synthesized riboflavin as they lack efficient riboflavin uptake machinery. As such, the enzymes responsible for riboflavin biosynthesis are promising targets for novel antibiotics. The individual enzymes responsible for riboflavin biosynthesis are slow with kinetic parameters insufficient to account for the amount of riboflavin being produced in vivo. In order to justify the disconnect between the rates of riboflavin formation in vivo and in vitro, we hypothesize that these enzymes assemble into a macromolecular machine with enhanced catalytic efficiency called the Riboflavinator. The riboflavin biosynthetic pathway is composed of two distinct branches that converge at the penultimate step of riboflavin formation. The enzymes of this pathway have been studied for decades across multiple organisms, but an essential phosphatase has remained largely elusive outside of a few reported bacteria . In order to understand the pathway in its entirety, we seek to identify the missing phosphatase of Aquifex aeolicus and detail protein-protein interactions that expedite riboflavin formation. This investigation combines kinetics, NMR, X-ray crystallography, and cryogenic electron microscopy to determine the mechanisms of the Riboflavinator's component parts, the individual enzymes, and generate a 3D blueprint of a macromolecular machine. The riboflavin biosynthetic pathway has been touted for decades as an ideal target for novel antibiotics, but decades of intense study has not yielded new antibiotics. For this reason, the Riboflavinator hypothesis represents A New Hope that understanding this pathway in its entirety will guide drug design to combat pathogenic bacteria. This work is funded by the National Science Foundation Grant CHE-2204080.
No takes yet. Share an insight, caveat, or question.
Hoffpauir et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: